| Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study PS Kulkarni, A Kadam, S Godbole, V Bhatt, A Raut, S Kohli, S Tripathi, ... The Lancet Regional Health-Southeast Asia 10, 2023 | 14 | 2023 |
| Comparison of efficacy and safety of escitalopram and vilazodone in major depressive disorder P Kudyar, BM Gupta, V Khajuria, R Banal National Journal of Physiology, Pharmacy and Pharmacology 8 (8), 1147-1152, 2018 | 5 | 2018 |
| Knowledge, attitude & practice towards self-medication among nursing students in a teaching hospital of north India P Kudyar, S Rani, P Malhotra IJPP 5, 159-63, 2019 | 3 | 2019 |
| Comparative evaluation of efficacy and safety of cyclosporine 0.1% add-on therapy with artificial tears (carboxymethylcellulose 0.5%) with artificial tears alone in post … P Kudyar, BM Gupta, D Gupta, V Khajuria National Journal of Physiology, Pharmacy and Pharmacology 8 (12), 1685-1685, 2018 | 2 | 2018 |
| Satisfaction and reasons for participation in a Covid-19 vaccine clinical trial reply P Kudyar, D Soni, NJ Gogtay NATIONAL MEDICAL JOURNAL OF INDIA 36 (3), 205-205, 2023 | | 2023 |
| Evaluation of clinical trials done for orphan drugs versus nonorphan drugs in infectious diseasesan eleven year analysis [2010-2020] P Kudyar, M Konwar, Z Khatri, NJ Gogtay, UM Thatte Perspectives in Clinical Research 14 (2), 56-60, 2023 | | 2023 |
| Evaluation of satisfaction and reasons for participation in a Covid-19 vaccine clinical trial: A single-centre, observational study. P Kudyar, D Soni, NJ Gogtay National Medical Journal of India 35 (4), 2022 | | 2022 |
| Comparison of efficacy of treatment with cyclosporine 0.1% add on therapy with artificial tears (carboxy methyl cellulose 0.5%) & artificial tears alone on dry eye parameters … P Kudyar, V Khajuria, BM Gupta Journal of Advanced Medical and Dental Sciences Research 6 (10), 49-53, 2018 | | 2018 |
